Global Injectable Anticoagulants Market Survey and Trend Research 2018
SUMMARY
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Injectable Anticoagulants Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 INJECTABLE ANTICOAGULANTS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Genentech (Roche) (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Sanofi (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Pfizer (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Aspen (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Aspen (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Otsuka (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Injectable Anticoagulants Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 INJECTABLE ANTICOAGULANTS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Genentech (Roche) (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Sanofi (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Pfizer (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Aspen (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Aspen (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Otsuka (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global Injectable Anticoagulants Market 2012-2017, by Type, in USD Million
Table Global Injectable Anticoagulants Market 2012-2017, by Type, in Volume
Table Global Injectable Anticoagulants Market Forecast 2018-2023, by Type, in USD Million
Table Global Injectable Anticoagulants Market Forecast 2018-2023, by Type, in Volume
Table Genentech (Roche) Overview List
Table Injectable Anticoagulants Business Operation of Genentech (Roche) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Injectable Anticoagulants Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Injectable Anticoagulants Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Injectable Anticoagulants Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Injectable Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Injectable Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Injectable Anticoagulants Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Injectable Anticoagulants Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Injectable Anticoagulants Sales Revenue Share, by Companies, in USD Million
Table Global Injectable Anticoagulants Sales Volume 2012-2017, by Companies, in Volume
Table Global Injectable Anticoagulants Sales Revenue Share, by Companies in 2017, in Volume
Table Injectable Anticoagulants Demand 2012-2017, by Application, in USD Million
Table Injectable Anticoagulants Demand 2012-2017, by Application, in Volume
Table Injectable Anticoagulants Demand Forecast 2018-2023, by Application, in USD Million
Table Injectable Anticoagulants Demand Forecast 2018-2023, by Application, in Volume
Table Global Injectable Anticoagulants Market 2012-2017, by Region, in USD Million
Table Global Injectable Anticoagulants Market 2012-2017, by Region, in Volume
Table Injectable Anticoagulants Market Forecast 2018-2023, by Region, in USD Million
Table Injectable Anticoagulants Market Forecast 2018-2023, by Region, in Volume
Table Global Injectable Anticoagulants Market 2012-2017, by Type, in USD Million
Table Global Injectable Anticoagulants Market 2012-2017, by Type, in Volume
Table Global Injectable Anticoagulants Market Forecast 2018-2023, by Type, in USD Million
Table Global Injectable Anticoagulants Market Forecast 2018-2023, by Type, in Volume
Table Genentech (Roche) Overview List
Table Injectable Anticoagulants Business Operation of Genentech (Roche) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Injectable Anticoagulants Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Injectable Anticoagulants Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Injectable Anticoagulants Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Injectable Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Injectable Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Injectable Anticoagulants Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Injectable Anticoagulants Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Injectable Anticoagulants Sales Revenue Share, by Companies, in USD Million
Table Global Injectable Anticoagulants Sales Volume 2012-2017, by Companies, in Volume
Table Global Injectable Anticoagulants Sales Revenue Share, by Companies in 2017, in Volume
Table Injectable Anticoagulants Demand 2012-2017, by Application, in USD Million
Table Injectable Anticoagulants Demand 2012-2017, by Application, in Volume
Table Injectable Anticoagulants Demand Forecast 2018-2023, by Application, in USD Million
Table Injectable Anticoagulants Demand Forecast 2018-2023, by Application, in Volume
Table Global Injectable Anticoagulants Market 2012-2017, by Region, in USD Million
Table Global Injectable Anticoagulants Market 2012-2017, by Region, in Volume
Table Injectable Anticoagulants Market Forecast 2018-2023, by Region, in USD Million
Table Injectable Anticoagulants Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Injectable Anticoagulants Industry Chain Structure
Figure Global Injectable Anticoagulants Market Growth 2012-2017, by Type, in USD Million
Figure Global Injectable Anticoagulants Market Growth 2012-2017, by Type, in Volume
Figure Global Injectable Anticoagulants Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Injectable Anticoagulants Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Injectable Anticoagulants Industry Chain Structure
Figure Global Injectable Anticoagulants Market Growth 2012-2017, by Type, in USD Million
Figure Global Injectable Anticoagulants Market Growth 2012-2017, by Type, in Volume
Figure Global Injectable Anticoagulants Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Injectable Anticoagulants Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region